• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Drug Eluting Stents, Bare Metal Stents: No Survival Difference

  • in General Medicine
  • — 2 Sep, 2007
Drug Eluting Stents, Bare Metal Stents: No Survival Difference
AudioMedica News
Drug Eluting Stents, Bare Metal Stents: No Survival Difference
Drug Eluting Stents, Bare Metal Stents: No Survival Difference
00:00 /
RSS Feed
Share
Link
Embed
//-->//>' class="input-embed input-embed-331"/>
Stefan James
Stefan James
Raymond Gibbons
Raymond Gibbons

REFERENCE: Hot Line 1 Sunday 11:00 2 Sept, European Society of Cardiology Congress, 2007, 1-5 September, Vienna, Austria
STEFAN JAMES, Uppsala Clinical Research Centre, Sweden
COMMENT: RAYMOND GIBBONS, Mayo Clinic, Rochester MN

Another year’s results of the long term outcome of using drug-eluting stents as compared with bare-metal stents from Sweden reveal that there is no longer an increased risk of late mortality when using drug-eluting stents according to Stefan James of Uppsala Clinical Research Centre. He suggested that improvements in technique have helped reduce the risk of death or myocardial infarction associated with using drug-eluting stents nevertheless the risk of blood clots still remains. Overall survival of patients was found to be the similar for both categories of stent.
Nicola Soloman interviewed Stefan James after his presentation at the European Society of Cardiology meeting in Vienna. Raymond Gibbons, president of the American Heart Association, added his comments.

[audio:https://www.audiomedica.com/podcasting/general_medicine/070902_stefan_james.mp3]

You may also like...

  • Audio Journal of Medicine – July 8th Audio Journal of Medicine – July 8th 7 Jul, 2006
  • Broad Approach, Including Computer System, to Improve Hospital Hygiene Broad Approach, Including Computer System, to Improve Hospital Hygiene 23 Sep, 2007
  • Bortezomib for Multiple Myeloma Can Cause Reactivation of Viruses Bortezomib for Multiple Myeloma Can Cause Reactivation of Viruses 19 Sep, 2007
  • Statins Protect Heart Patients from Sepsis Statins Protect Heart Patients from Sepsis 14 Feb, 2006

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Previous story Blood Pressure Drugs Reduce Mortality in Patients with Diabetes: The ADVANCE Study
  • Next story Immediate Angioplasty After Throbolysis Can Save Lives
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic…
    • New Front Line Standard for Older Patients with…
    • Microbiome Diversity Key To Survival After…
    • PD-L1 Immunotherapy Delayed Triple Negative Breast…
    • Image-Guided Radiotherapy: Positioning Errors Affect…
  • Home
  • General Medicine
  • Drug Eluting Stents, Bare Metal Stents: No Survival Difference

© COPYRIGHT 2020 AUDIOMEDICA.COM.